<DOC>
	<DOC>NCT00365339</DOC>
	<brief_summary>The purpose of this clinical research study is to assess the pharmacokinetics of atazanavir, identifying one or more dosing regimens of atazanavir/ritonavir/tenofovir when dosed with famotidine results in atazanavir exposures similar to those when atazanavir/ritonavir/tenofovir 300/100/300 mg is dosed without famotidine in healthy subjects.</brief_summary>
	<brief_title>Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Healthy male and female subjects between the ages 18 to 50 years old with a BMI 18 to 32 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>HIV</keyword>
	<keyword>Protease Inhibitor</keyword>
</DOC>